Sylatron (peginterferon alfa-2b) Drug Interactions
A total of 190 drugs (638 brand and generic names) are known to interact with Sylatron (peginterferon alfa-2b).
- 24 major drug interactions (98 brand and generic names)
- 161 moderate drug interactions (522 brand and generic names)
- 5 minor drug interactions (18 brand and generic names)
Check for interactions with Sylatron (peginterferon alfa-2b)
Common medications checked in combination with Sylatron (peginterferon alfa-2b)
- Astelin (azelastine nasal)
- Breo Ellipta (fluticasone / vilanterol)
- Calcium 600 D (calcium / vitamin d)
- CoQ10 (ubiquinone)
- Effexor XR (venlafaxine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- guaifenesin
- Klonopin (clonazepam)
- Lasix (furosemide)
- Lopid (gemfibrozil)
- multivitamin
- Nexium (esomeprazole)
- Q-Sorb Co Q-10 (ubiquinone)
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Valium (diazepam)
- Vytorin (ezetimibe / simvastatin)
- Vyvanse (lisdexamfetamine)
- Zyrtec (cetirizine)
Sylatron (peginterferon alfa-2b) disease Interactions
There are 20 disease interactions with Sylatron (peginterferon alfa-2b) which include:
- Renal Dysfunction
- Autoimmune Diseases
- Cardiac Disease
- Cns Dysfunction
- Depression
- Thyroid Dysfunction
- Autoimmune Hepatitis
- Depression
- Severe Hepatic Disease
- Hemoglobinopathies
- Renal Dysfunction
- Colitis
- Diabetes Mellitus
- Myelosuppression
- Peripheral Neuropathy
- Bone Marrow Suppression
- Endocrine Disorders
- Ophthalmological Disorders
- Pancreatitis
- Pulmonary Disorders
See also...
Drug Interaction Classification
The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2017 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
